IMCR
Price
$30.36
Change
+$0.56 (+1.88%)
Updated
Apr 24 closing price
Capitalization
1.5B
12 days until earnings call
IMNM
Price
$8.52
Change
+$0.02 (+0.24%)
Updated
Apr 24 closing price
Capitalization
740.82M
13 days until earnings call
Ad is loading...

IMCR vs IMNM

Header iconIMCR vs IMNM Comparison
Open Charts IMCR vs IMNMBanner chart's image
Immunocore Holdings
Price$30.36
Change+$0.56 (+1.88%)
Volume$231.51K
Capitalization1.5B
Immunome
Price$8.52
Change+$0.02 (+0.24%)
Volume$1.33M
Capitalization740.82M
IMCR vs IMNM Comparison Chart
Loading...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMCR vs. IMNM commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMCR is a Buy and IMNM is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (IMCR: $30.36 vs. IMNM: $8.52)
Brand notoriety: IMCR and IMNM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMCR: 64% vs. IMNM: 116%
Market capitalization -- IMCR: $1.5B vs. IMNM: $740.82M
IMCR [@Biotechnology] is valued at $1.5B. IMNM’s [@Biotechnology] market capitalization is $740.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMCR’s FA Score shows that 0 FA rating(s) are green whileIMNM’s FA Score has 0 green FA rating(s).

  • IMCR’s FA Score: 0 green, 5 red.
  • IMNM’s FA Score: 0 green, 5 red.
According to our system of comparison, IMCR is a better buy in the long-term than IMNM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMCR’s TA Score shows that 6 TA indicator(s) are bullish while IMNM’s TA Score has 6 bullish TA indicator(s).

  • IMCR’s TA Score: 6 bullish, 3 bearish.
  • IMNM’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, both IMCR and IMNM are a good buy in the short-term.

Price Growth

IMCR (@Biotechnology) experienced а +6.86% price change this week, while IMNM (@Biotechnology) price change was +7.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.06%. For the same industry, the average monthly price growth was -5.30%, and the average quarterly price growth was -11.62%.

Reported Earning Dates

IMCR is expected to report earnings on Aug 06, 2025.

IMNM is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+8.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCR($1.5B) has a higher market cap than IMNM($741M). IMCR YTD gains are higher at: 2.915 vs. IMNM (-19.774). IMCR has higher annual earnings (EBITDA): -29.89M vs. IMNM (-109.95M). IMCR has more cash in the bank: 820M vs. IMNM (240M). IMNM has less debt than IMCR: IMNM (2.72M) vs IMCR (433M). IMCR has higher revenues than IMNM: IMCR (310M) vs IMNM (10.1M).
IMCRIMNMIMCR / IMNM
Capitalization1.5B741M202%
EBITDA-29.89M-109.95M27%
Gain YTD2.915-19.774-15%
P/E RatioN/AN/A-
Revenue310M10.1M3,069%
Total Cash820M240M342%
Total Debt433M2.72M15,913%
TECHNICAL ANALYSIS
Technical Analysis
IMCRIMNM
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
85%
Bearish Trend 17 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINGX38.28N/A
N/A
MFS International Intrinsic Value R3
HGHCX22.18N/A
N/A
Hartford Healthcare C
SGFCX38.98N/A
N/A
Sparrow Growth C
RGYTX9.38N/A
N/A
Russell Inv Multi-Strategy Income M
GGKPX25.49N/A
N/A
Goldman Sachs Income Builder P